CTEG: Understanding clinical adoption: How a therapy is reimbursed.

A presentation by Nancy Sikich, MSc (Health Quality Ontario) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

In this seminar, Nancy Sikich discusses the role of Health Quality Ontario (HQO) in assessing and implementing innovations within a healthcare framework. Through a series of examples, this seminar covers how health technologies are assessed, evaluated for adoption and the reimbursement pathway of new technologies.

This video is presented by the Clinical Translation Education Group: BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine and Stem Cell Network.

MaRS Centre, West Tower
661 University Avenue, Suite 1002
Toronto, Ontario M5G 1M1 Canada
t: 416-978-3751
f: 416-978-1368

We wish to acknowledge this land on which CCRM operates. For thousands of years, it has been the traditional land of the Huron-Wendat, the Seneca, and the Mississaugas of the Credit. Today, this meeting place is still the home to many Indigenous people from across Turtle Island and we are grateful to have the opportunity to work on this land.